Home » Healthcare » Oral Syringes Market

Oral Syringes Market By Product Type (Standard Oral Syringes, Graduated Oral Syringes, Oral Syringes with Integrated Features); By Material (Plastic, Glass Oral Syringes); By Size (Small [1-5 ml], Medium [6-10 ml], Large [11-20 ml]); By Usage (Single-use, Reusable Oral Syringes); By End Use (Hospitals, Clinics, Home Care Settings, Other Healthcare Facilities); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $3699

Published: | Report ID: 50507 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2019-2022
Base Year 2023
Forecast Period 2024-2032
Oral Syringes Market Size 2024 USD 22484.6 million
Oral Syringes Market, CAGR 8.96%
Oral Syringes Market Size 2032 USD 44670.61 million

Market Overview:

The Oral Syringes market is projected to grow from USD 22484.6 million in 2024 to an estimated USD 44670.61 million by 2032, with a compound annual growth rate (CAGR) of 8.96% from 2024 to 2032.

Several key factors are driving the growth of the oral syringes market. Firstly, the rising prevalence of chronic diseases and pediatric conditions necessitates accurate and convenient medication administration, which oral syringes facilitate effectively. Additionally, technological advancements in syringe design, such as features that enhance precision and minimize medication wastage, are contributing to market expansion. The growing emphasis on home healthcare and patient self-management is also fueling demand, as oral syringes offer a user-friendly solution for administering medications outside clinical settings. Furthermore, regulatory support and increasing healthcare expenditures globally are creating a favorable environment for market growth. These factors collectively drive the adoption of oral syringes across various healthcare settings.

Regionally, North America holds a significant share of the oral syringes market, driven by advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of key market players. The United States, in particular, contributes substantially to the market due to its large patient population and high demand for accurate medication administration solutions. Europe follows closely, with growth fueled by increasing healthcare investments and a rising focus on patient safety. The Asia-Pacific region is experiencing rapid growth, attributed to improving healthcare facilities, rising disposable incomes, and an expanding patient population. Emerging economies in this region are witnessing increased adoption of oral syringes due to growing awareness and healthcare access improvements. Latin America and the Middle East & Africa are also expected to see growth, driven by enhancing healthcare systems and increasing healthcare needs.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Drivers:

Growing Prevalence of Chronic and Pediatric Conditions:

The increasing prevalence of chronic diseases and pediatric conditions is a significant driver for the oral syringes market. Chronic illnesses such as diabetes, cardiovascular diseases, and respiratory disorders require regular and accurate medication administration to manage symptoms effectively. Oral syringes provide a precise method for dosing, which is crucial for patients with conditions that demand consistent medication adherence. Similarly, in pediatric care, the precise dosing of medications is critical, given the varying dosages based on age and weight. Oral syringes are specifically designed to cater to these needs by offering accuracy and ease of use, which supports their growing adoption in both chronic and pediatric treatments.

Technological Advancements and Innovation:

Technological advancements in syringe design and manufacturing have significantly contributed to the growth of the oral syringes market. Innovations such as the development of syringes with enhanced accuracy, reduced medication wastage, and ergonomic designs have made oral syringes more appealing to both healthcare providers and patients. The integration of features like graduations and easy-to-read scales ensures precise dosing, which is essential for effective treatment. Additionally, advancements in materials and production techniques have led to the creation of syringes that are more durable, safe, and comfortable to use. These technological improvements have positioned oral syringes as a preferred choice in various healthcare settings, driving market expansion.

Rise in Home Healthcare and Patient Self-Management:

The rise in home healthcare and patient self-management is another critical driver of the oral syringes market. As healthcare shifts towards more patient-centered approaches, there is an increasing demand for tools that enable patients to manage their health at home effectively. Oral syringes are particularly advantageous in this context, offering a convenient and user-friendly method for administering medication. They support patient autonomy and adherence to prescribed treatments, which is increasingly important as the healthcare system focuses on reducing hospital visits and empowering patients to take control of their health. For instance, according to the National Health Care Surveys conducted by the Centers for Disease Control and Prevention (CDC), approximately 1.4 million patients in the United States received home healthcare in 2018. This significant number underscores the growing trend towards home-based care and the potential demand for tools like oral syringes

Regulatory Support and Healthcare Investments:

Regulatory support and increasing healthcare investments are fostering a positive environment for the oral syringes market. Government regulations and standards that emphasize medication accuracy and patient safety have led to greater adoption of oral syringes, as they align with these requirements. For instance, according to the National Health Expenditure Accounts (NHEA) conducted by the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending grew 2.7% to reach $4.3 trillion in 2021, or $12,914 per person. This increased healthcare expenditure indicates a growing investment in medical devices and technologies, including oral syringes. Additionally, rising healthcare expenditures globally, particularly in emerging markets, are enhancing access to advanced medical devices, including oral syringes. Investments in healthcare infrastructure and technology improvements are facilitating the growth of the market by making these devices more accessible and affordable. As regulatory frameworks continue to support innovations in healthcare, the demand for oral syringes is expected to rise accordingly.

Market Trends:

Shift Towards Eco-Friendly Materials:

One prominent trend in the oral syringes market is the shift towards the use of eco-friendly materials. As environmental concerns grow, both manufacturers and consumers are increasingly focused on sustainability. Companies are investing in the development of syringes made from biodegradable or recyclable materials, which aim to reduce the environmental impact associated with medical waste. This trend reflects a broader industry movement towards greener practices and aligns with global efforts to promote environmental stewardship. By adopting sustainable materials, manufacturers not only address environmental concerns but also meet the increasing consumer demand for eco-friendly healthcare solutions.

Enhanced Precision and User Experience:

Another significant trend is the enhancement of precision and user experience in oral syringes. Technological advancements are driving improvements in syringe design to ensure more accurate dosing and ease of use. Features such as clearer graduations, improved plunger mechanisms, and ergonomic designs are becoming standard. These innovations cater to both healthcare professionals and patients, facilitating more reliable medication administration. For instance, according to the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance (NEISS-CADES) project, conducted by the Centers for Disease Control and Prevention (CDC), an estimated 13,500 emergency department visits for medication errors involving liquid medications occurred annually from 2012-2015 in the United States. This data underscores the importance of precise dosing devices like improved oral syringes. Enhanced precision reduces the risk of dosing errors, which is crucial for effective treatment, while user-friendly designs improve overall satisfaction and adherence. This trend reflects a growing emphasis on patient safety and the need for user-centric medical devices.

Increased Adoption of Digital and Smart Syringes:

The integration of digital technology into oral syringes is a rising trend within the market. Digital or smart syringes, equipped with features such as dosage tracking, reminder systems, and real-time monitoring, are becoming more prevalent. These advanced devices offer the potential for improved medication adherence by providing users with alerts and tracking capabilities. For healthcare providers, digital syringes can facilitate better management of patient treatments through data collection and analysis. For instance, the Centers for Medicare & Medicaid Services (CMS) reported in the National Health Expenditure Accounts (NHEA) that U.S. healthcare spending grew 2.7% to reach $4.3 trillion in 2021, or $12,914 per person. This increased healthcare expenditure indicates a growing investment in medical devices and technologies, including advanced syringes, as part of the overall trend towards digital health solutions. The adoption of such smart technologies aligns with the broader trend towards digital health solutions and the increasing focus on personalized medicine and patient engagement.

Growth in Emerging Markets:

The oral syringes market is also experiencing significant growth in emerging markets, driven by increasing healthcare investments and improving infrastructure. Countries in regions such as Asia-Pacific, Latin America, and the Middle East are expanding their healthcare systems and enhancing access to medical devices, including oral syringes. This growth is fueled by rising disposable incomes, a growing patient population, and increasing awareness of advanced healthcare products. As these markets develop, there is a heightened demand for precise and reliable medication administration tools, contributing to the expansion of the oral syringes market. This trend highlights the evolving landscape of global healthcare and the opportunities present in developing regions.

Market Restraints and Challenges:

High Cost of Advanced Syringe Technologies:

One significant restraint in the oral syringes market is the high cost associated with advanced syringe technologies. While innovations such as digital syringes and those made from eco-friendly materials offer numerous benefits, their higher production costs can limit widespread adoption. These advanced syringes often come with a premium price tag, which can be a barrier for healthcare providers and patients, particularly in cost-sensitive environments. The initial investment required for advanced syringe technologies may not always be justifiable for all users, potentially hindering market growth.

Regulatory and Compliance Challenges:

Regulatory and compliance challenges also pose a restraint for the oral syringes market. The production and distribution of medical devices, including oral syringes, are subject to stringent regulations and standards set by health authorities across different regions. Navigating these complex regulatory frameworks can be time-consuming and costly for manufacturers. Additionally, compliance with varying regional regulations can complicate global market entry and expansion. These challenges can slow down the introduction of new products and innovations, impacting market dynamics.

Market Competition and Price Pressure:

Intense market competition is another challenge affecting the oral syringes market. The presence of numerous players and the availability of low-cost alternatives can lead to price pressures, affecting profit margins for manufacturers. Competitive pricing strategies by established players and new entrants alike can lead to reduced revenues and increased pressure to continuously innovate while managing costs. This competitive landscape necessitates a strategic approach to pricing and product differentiation, which can be challenging for many companies.

Limited Awareness and Adoption in Emerging Markets:

In emerging markets, limited awareness and adoption of oral syringes present a challenge. Despite growing healthcare investments, there is often a lack of familiarity with advanced medical devices and their benefits. This can result in slower adoption rates and lower demand compared to more developed regions. Additionally, infrastructure limitations and lower disposable incomes in these markets can restrict the availability and use of oral syringes, hindering market growth potential in these areas.

Market Segmentation Analysis:

By Product Type:

The oral syringes market is segmented by product type into standard oral syringes, graduated oral syringes, and oral syringes with integrated features. Standard oral syringes are the most widely used, offering basic functionality for medication administration. Graduated oral syringes, which include clear measurement markings, are gaining popularity for their precision. Syringes with integrated features, such as digital displays and dosage tracking, are increasingly sought after due to their advanced functionality and enhanced accuracy.

By Material:

The market is segmented by material into plastic and glass oral syringes. Plastic syringes dominate the market due to their lightweight, durability, and cost-effectiveness. They are commonly used in both healthcare settings and home care. Glass syringes, while less common, are preferred in certain applications for their chemical resistance and ease of sterilization.

By Size:

Oral syringes are available in various sizes, including small (1-5 ml), medium (6-10 ml), and large (11-20 ml). Smaller sizes are typically used for pediatric patients and precise dosing, while larger sizes are utilized for adult medications and bulk dosing. The size selection often depends on the specific medication requirements and patient needs.

By Usage:

The usage segment includes single-use and reusable oral syringes. Single-use syringes are preferred for their convenience and reduced risk of cross-contamination, making them ideal for one-time applications. Reusable syringes, which can be sterilized and used multiple times, are often chosen for their cost-effectiveness and sustainability in clinical settings.

By End Use:

The end-use segment encompasses hospitals, clinics, home care settings, and other healthcare facilities. Hospitals and clinics are major consumers due to their high volume of medication administration. The home care segment is growing rapidly as more patients manage their treatments independently, driving demand for user-friendly and accurate oral syringes.

Segmentation:

By Product Type:

  • Standard oral syringes,
  • Graduated oral syringes,
  • Oral syringes with integrated features.

By Material:

  • Plastic
  • Glass oral syringes.

By Size:

  • Small (1-5 ml),
  • Medium (6-10 ml),
  • Large (11-20 ml).

By Usage:

  • Single-use
  • Reusable oral syringes.

By End Use:

  • Hospitals
  • Clinics
  • Home care settings
  • Other healthcare facilities.

By Region

  • North America
    • The U.S
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Regional Analysis:

North America

North America dominates the oral syringes market, accounting for a significant share of approximately 40% in 2023. The region’s leading position is attributed to its advanced healthcare infrastructure, high healthcare expenditure, and strong presence of major market players. The United States, in particular, is a major contributor due to its large patient population, high demand for precise medication administration, and substantial investments in healthcare technology. Regulatory support and a focus on improving patient safety further bolster market growth. Canada also contributes to the region’s dominance with a growing emphasis on home healthcare and innovative medical devices.

Europe

Europe holds a substantial share of around 30% of the global oral syringes market. The region benefits from a robust healthcare system and significant investments in healthcare infrastructure. Countries like Germany, France, and the United Kingdom are key markets within Europe, driven by their advanced healthcare facilities and increasing demand for accurate medication administration tools. The European market is also supported by stringent regulations that promote patient safety and quality in medical devices. Growth is further fueled by rising healthcare expenditures and a focus on improving patient outcomes through innovative solutions.

Asia-Pacific

The Asia-Pacific region is experiencing rapid growth in the oral syringes market, with a market share of approximately 20%. This growth is driven by improving healthcare infrastructure, rising disposable incomes, and a large and expanding patient population. Countries such as China and India are leading the growth due to increasing healthcare investments and a growing awareness of advanced medical devices. Additionally, the rise of home healthcare solutions and a growing emphasis on patient-centered care contribute to the increasing adoption of oral syringes. However, the market faces challenges such as varying regulatory standards and infrastructure limitations in some areas.

Latin America and Middle East & Africa

Latin America and the Middle East & Africa collectively hold a market share of about 10%. In Latin America, growth is driven by increasing healthcare access and investments in medical infrastructure, although economic constraints and lower awareness levels can impact market penetration. The Middle East & Africa region is also seeing growth, supported by improving healthcare systems and rising healthcare spending. However, the market in these regions faces challenges such as economic disparities and limited access to advanced healthcare solutions, which can affect the adoption rates of oral syringes.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Player Analysis:

  • Amcor Limited
  • Baxter Healthcare Corporation
  • Becton
  • Braun Melsungen AG
  • Cardinal Health.
  • Comar LLC
  • Dickinson and Company
  • GBUK Enteral Ltd.
  • Gerresheimer AG
  • Medtronic
  • NIPRO Corporation
  • Smiths Medical
  • Terumo Corporation

Competitive Analysis:

The oral syringes market is highly competitive, characterized by the presence of several prominent players striving for market share through innovation and strategic positioning. Key companies, such as BD (Becton, Dickinson and Company), Gerresheimer AG, and Baxter International Inc., lead the market by leveraging their extensive expertise in medical device manufacturing and advanced technology integration. These leaders focus on enhancing product precision, improving user experience, and introducing eco-friendly materials to cater to evolving market demands. Additionally, mid-sized and emerging companies are increasingly entering the market, offering competitive pricing and niche products to differentiate themselves. Strategic alliances, mergers, and acquisitions are common as companies seek to expand their product portfolios and geographical reach. The competitive landscape is further intensified by the need for regulatory compliance and continuous innovation, driving companies to invest in research and development to maintain a competitive edge.

Recent Developments:

  • In March 2024, the FDA advised U.S. health care organizations to immediately transition away from using certain unauthorized plastic syringes made in China by Jiangsu Caina Medical Co. and Jiangsu Shenli Medical Production Co., citing potential quality and performance issues

Market Concentration & Characteristics:

The oral syringes market exhibits moderate concentration, with a few major players dominating the sector while a number of smaller firms also contribute to its dynamics. Leading companies such as BD (Becton, Dickinson and Company), Gerresheimer AG, and Baxter International Inc. hold substantial market shares due to their advanced technology, extensive distribution networks, and strong brand recognition. These key players are characterized by their focus on innovation, quality control, and compliance with stringent regulatory standards. The market is also characterized by a diverse range of product offerings, including standard and advanced oral syringes. Companies are investing in R&D to introduce new features such as enhanced precision and eco-friendly materials. Despite the presence of major players, the market is dynamic, with emerging firms and new entrants providing competitive pricing and specialized solutions, contributing to a competitive and evolving market landscape

Report Coverage:

The research report offers an in-depth analysis based on By Product type, By Material, By size, By usage, and By End use. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

  • The oral syringes market is expected to continue growing at a steady pace, driven by increasing demand for accurate and user-friendly medication administration.
  • Advancements in syringe technology, including digital and smart syringes, will likely drive innovation and expand market opportunities.
  • Rising awareness and adoption of eco-friendly materials will promote the development and use of sustainable oral syringes.
  • The expansion of home healthcare and patient self-management will boost the demand for oral syringes as convenient and reliable dosing tools.
  • Emerging markets, particularly in Asia-Pacific and Latin America, will experience significant growth due to improving healthcare infrastructure and rising disposable incomes.
  • Regulatory support and stricter safety standards will enhance the focus on precision and quality in oral syringes.
  • Increased investment in healthcare technology and research will lead to new product innovations and enhancements.
  • Competitive pricing and the introduction of cost-effective solutions will influence market dynamics and accessibility.
  • Strategic mergers and acquisitions among key players will shape market structure and expand product offerings.
  • Growing emphasis on personalized medicine and patient-centric care will drive the demand for tailored and advanced oral syringe solutions.

For Table OF Content – Request For Sample Report

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Frequently Asked Questions

What is the projected growth of the oral syringes market?

The market is projected to grow from USD 22,484.6 million in 2024 to USD 44,670.61 million by 2032, with a CAGR of 8.96% from 2024 to 2032.

What factors are driving the growth of the oral syringes market?

Key drivers include the rising prevalence of chronic and pediatric conditions, technological advancements in syringe design, increasing emphasis on home healthcare, and regulatory support.

Which region leads the oral syringes market?

North America holds a significant market share, driven by advanced healthcare infrastructure, high expenditure, and a strong presence of key market players.

What challenges does the oral syringes market face?

Challenges include high costs of advanced syringe technologies, regulatory and compliance hurdles, intense market competition, and limited awareness in emerging markets.

Oral Thin Films Market

Published:
Report ID: 46502

Behavioral Analytics Market

Published:
Report ID: 45609

Oral Dosing Cups Market

Published:
Report ID: 44713

Oral Solid Dosage Manufacturing Market

Published:
Report ID: 41090

Digital Intraoral Sensor and Consumable Market

Published:
Report ID: 35017

Oral Macromolecular Formulation Market

Published:
Report ID: 34861

Standalone Intraoral Scanners Market

Published:
Report ID: 9690

Vietnam Oral Solid Dosage Contract Manufacturing Market

Published:
Report ID: 32341

Europe Oral Solid Dosage Contract Manufacturing Market

Published:
Report ID: 32265

Primary Sclerosing Cholangitis Market

Published:
Report ID: 55081

Healthcare Informatics Market

Published:
Report ID: 54414

Healthcare Distribution Market

Published:
Report ID: 54409

Healthcare Consumables Market

Published:
Report ID: 54403

Radioisotope Market

Published:
Report ID: 54966

Contract Pharmaceutical Manufacturing Market

Published:
Report ID: 54812

Mental Health Software Market

Published:
Report ID: 54802

Foot And Mouth Disease (FMD) Vaccines Market

Published:
Report ID: 5648

Donor Egg IVF Market

Published:
Report ID: 48687

Bioplastic Composites Market For Injection Molding

Published:
Report ID: 54506

Animal Growth Promoters Performance Enhancers Market

Published:
Report ID: 54556

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$3699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$4699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$6699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN